Trafalgar International Reports Q2 Profit on Debt Cancellation, But Going Concern Doubt Persists
GCAN has more than doubled off its 52-week low of $0.036 on light trading volume (0.3× avg).
Summary
Trafalgar International's Q2 2026 10-Q shows a profit from debt cancellation but only $111 in cash and a going concern warning through June 2027.
Key Events · Earnings and Guidance · GCAN
-
Going Concern Warning
Management states substantial doubt about the company's ability to continue as a going concern through June 2027, with cash of $111 and negative working capital of $12,128 as of June 30, 2026.
-
Q2 Profit from Debt Cancellation
Net income of $611,378 for Q2 2026 was driven by a $621,450 gain on cancellation of debt, compared to a net loss of $390,853 in Q2 2025.
-
Restatement of Q1 2025
The company restated Q1 2025 financials to correct FirstFire note terms, recording $138,906 in default penalties and interest as of March 31, 2025.
-
New Executive Appointments
On July 29, 2026, the board appointed Carlos Septién as COO, Michelle Cervantes Vivanco as CFO, and Ernesto Gómez Berjón as CGO, all also joining the board.
Analysis · GCAN · Life Sciences
The company's first quarterly report under new controlling shareholder Trafalgar Asset Management shows a net profit of $611,378 for Q2 2026, entirely driven by a $621,450 gain from debt cancellation. However, the company has only $111 in cash and negative working capital of $12,128, and management states substantial doubt about its ability to continue as a going concern through June 2027. The filing also restates Q1 2025 financials to correct a note agreement, adding $138,906 in default penalties. This is a critical update on the company's financial viability following the change of control.
At the time of this filing, GCAN was trading at $0.23 on OTC in the Life Sciences sector, with a market capitalization of approximately $228.8K. The 52-week trading range was $0.04 to $3.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.